Emerging Roles for Native Orai Ca2+ Channels in Cardiovascular Disease

Current Topics in Membranes

Volumn 71, Issue , 2013, Pages 209-235

  Ruhle, Brian ^a   Trebak, Mohamed ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cardiovascular disease; Endothelial cells; Orai1; Orai3; Stromal interaction molecule 1; Vascular smooth muscle cells

Indexed keywords

EID: 84880708746     PISSN: 10635823     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-407870-3.00009-3     Document Type: Chapter

References (121)

1. Abdullaev I.F., Bisaillon J.M., Potier M., Gonzalez J.C., Motiani R.K., Trebak M. Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation. Circulation Research 2008, 103(11):1289-1299. 01.RES.0000338496.95579.56 [pii]. 10.1161/01.RES.0000338496.95579.56.
2. Aird W.C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003, 101(10):3765-3777. 10.1182/blood-2002-06-1887.
3. Aird W.C. Spatial and temporal dynamics of the endothelium. Journal of Thrombosis and Haemostasis 2005, 3(7):1392-1406. 10.1111/j.1538-7836.2005.01328.x.
4. Aird W.C. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circulation Research 2007, 100(2):158-173. 10.1161/01.RES.0000255691.76142.4a.
5. Antigny F., Girardin N., Frieden M. Transient receptor potential canonical channels are required for in vitro endothelial tube formation. The Journal of Biological Chemistry 2012, 287(8):5917-5927. 10.1074/jbc.M111.295733.
6. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275(5302):964-967.
7. Aubart F.C., Sassi Y., Coulombe A., Mougenot N., Vrignaud C., Leprince P., et al. RNA interference targeting STIM1 suppresses vascular smooth muscle cell proliferation and neointima formation in the rat. Molecular Therapy 2009, 17(3):455-462. mt2008291 [pii]. 10.1038/mt.2008.291.
8. 2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. American Journal of Physiology. Cell Physiology 2008, 295(3):C779-C790. 00173.2008 [pii]. 10.1152/ajpcell.00173.2008.
9. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002, 415(6868):198-205. 10.1038/415198a.
10. Bisaillon J.M., Motiani R.K., Gonzalez-Cobos J.C., Potier M., Halligan K.E., Alzawahra W.F., et al. Essential role for STIM1/Orai1-mediated calcium influx in PDGF-induced smooth muscle migration. American Journal of Physiology. Cell Physiology 2010, 298(5):C993-C1005. 10.1152/ajpcell.00325.2009.
11. 2+ entry and vascular tone in intact aorta. American Journal of Physiology. Heart and Circulatory Physiology 2008, 295(6):H2466-H2474. 10.1152/ajpheart.00639.2008.
12. Bolton T.B., Gordienko D.V., Povstyan O.V., Harhun M.I., Pucovsky V. Smooth muscle cells and interstitial cells of blood vessels. Cell Calcium 2004, 35(6):643-657. 10.1016/j.ceca.2004.01.018.
13. 2+ levels. Cell 2007, 131(7):1327-1339.
14. Carmeliet P., Jain R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473(7347):298-307. 10.1038/nature10144.
15. Chen X., Nakayama H., Zhang X., Ai X., Harris D.M., Tang M., et al. Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy. Journal of Molecular and Cellular Cardiology 2011, 50(3):460-470. 10.1016/j.yjmcc.2010.11.012.
16. 2+ concentration. Stem Cells 2011, 29(11):1898-1907. 10.1002/stem.734.
17. Dzau V.J., Braun-Dullaeus R.C., Sedding D.G. Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies. Nature Medicine 2002, 8(11):1249-1256. 10.1038/nm1102-1249.
18. Eisner D.A., Diaz M.E., O'Neill S.C., Trafford A.W. Physiological and pathological modulation of ryanodine receptor function in cardiac muscle. Cell Calcium 2004, 35(6):583-589. 10.1016/j.ceca.2004.01.012.
19. Estrada I.A., Donthamsetty R., Debski P., Zhou M.H., Zhang S.L., Yuan J.X., et al. STIM1 restores coronary endothelial function in type 1 diabetic mice. Circulation Research 2012, 111(9):1166-1175. 10.1161/CIRCRESAHA.112.275743.
20. Faehling M., Kroll J., Fohr K.J., Fellbrich G., Mayr U., Trischler G., et al. Essential role of calcium in vascular endothelial growth factor A-induced signaling: Mechanism of the antiangiogenic effect of carboxyamidotriazole. The FASEB Journal 2002, 16(13):1805-1807. 10.1096/fj.01-0938fje.
21. Fasolato C., Nilius B. Store depletion triggers the calcium release-activated calcium current (ICRAC) in macrovascular endothelial cells: A comparison with Jurkat and embryonic kidney cell lines. Pflügers Archiv 1998, 436(1):69-74.
22. 2+ entry in the immune system and beyond. Immunological Reviews 2009, 231(1):189-209. 10.1111/j.1600-065X.2009.00818.x.
23. Feske S. Immunodeficiency due to defects in store-operated calcium entry. Annals of the New York Academy of Sciences 2011, 1238:74-90. 10.1111/j.1749-6632.2011.06240.x.
24. Feske S., Gwack Y., Prakriya M., Srikanth S., Puppel S.H., Tanasa B., et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006, 441(7090):179-185. nature04702 [pii]. 10.1038/nature04702.
25. Fierro L., Parekh A.B. Fast calcium-dependent inactivation of calcium release-activated calcium current (CRAC) in RBL-1 cells. The Journal of Membrane Biology 1999, 168(1):9-17.
26. Gandhirajan R.K., Meng S., Chandramoorthy H.C., Mallilankaraman K., Mancarella S., Gao H., et al. Blockade of NOX2 and STIM1 signaling limits lipopolysaccharide-induced vascular inflammation. Journal of Clinical Investigation 2013, 123(2):887-902. 10.1172/JCI65647.
27. Garnier-Raveaud S., Usson Y., Cand F., Robert-Nicoud M., Verdetti J., Faury G. Identification of membrane calcium channels essential for cytoplasmic and nuclear calcium elevations induced by vascular endothelial growth factor in human endothelial cells. Growth Factors 2001, 19(1):35-48.
28. Giachini F.R., Chiao C.W., Carneiro F.S., Lima V.V., Carneiro Z.N., Dorrance A.M., et al. Increased activation of stromal interaction molecule-1/Orai-1 in aorta from hypertensive rats: A novel insight into vascular dysfunction. Hypertension 2009, 53(2):409-416.
29. Gomez D., Owens G.K. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovascular Research 2012, 95(2):156-164. 10.1093/cvr/cvs115.
30. Gonzalez-Cobos J.C., Zhang X., Zhang W., Ruhle B.C., Motiani R.K., Schindl R., et al. Store-independent Orai1/3 channels activated by intracrine leukotrieneC4: Role in neointimal hyperplasia. Circulation Research 2013, 112:1013-1025. 10.1161/CIRCRESAHA.111.300220.
31. Guo R.W., Wang H., Gao P., Li M.Q., Zeng C.Y., Yu Y., et al. An essential role for stromal interaction molecule 1 in neointima formation following arterial injury. Cardiovascular Research 2009, 81(4):660-668. cvn338 [pii]. 10.1093/cvr/cvn338.
32. Gwack Y., Srikanth S., Feske S., Cruz-Guilloty F., Oh-hora M., Neems D.S., et al. Biochemical and functional characterization of Orai proteins. The Journal of Biological Chemistry 2007, 282(22):16232-16243. M609630200 [pii]. 10.1074/jbc.M609630200.
33. Gwack Y., Srikanth S., Oh-Hora M., Hogan P.G., Lamperti E.D., Yamashita M., et al. Hair loss and defective T- and B-cell function in mice lacking ORAI1. Molecular and Cellular Biology 2008, 28(17):5209-5222. MCB.00360-08 [pii]. 10.1128/MCB.00360-08.
34. Harrell M.D., Harbi S., Hoffman J.F., Zavadil J., Coetzee W.A. Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. Physiological Genomics 2007, 28(3):273-283. 10.1152/physiolgenomics.00163.2006.
35. 2+ transients and arrhythmias associated with cardiac hypertrophy. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(27):11406-11411. 10.1073/pnas.0905485106.
36. Hawkins B.J., Irrinki K.M., Mallilankaraman K., Lien Y.C., Wang Y., Bhanumathy C.D., et al. S-glutathionylation activates STIM1 and alters mitochondrial homeostasis. The Journal of Cell Biology 2010, 190(3):391-405. 10.1083/jcb.201004152.
37. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nature Reviews. Molecular Cell Biology 2006, 7(8):589-600. 10.1038/nrm1983.
38. Heineke J., Ritter O. Cardiomyocyte calcineurin signaling in subcellular domains: From the sarcolemma to the nucleus and beyond. Journal of Molecular and Cellular Cardiology 2012, 52(1):62-73. 10.1016/j.yjmcc.2011.10.018.
39. Hill J.A., Olson E.N. Cardiac plasticity. The New England Journal of Medicine 2008, 358(13):1370-1380. 10.1056/NEJMra072139.
40. Hirano K. The roles of proteinase-activated receptors in the vascular physiology and pathophysiology. Arteriosclerosis, Thrombosis, and Vascular Biology 2007, 27(1):27-36. 10.1161/01.ATV.0000251995.73307.2d.
41. 2+ influx in vascular endothelial cells. Journal of Cellular Biochemistry 2009, 108(2):499-507. 10.1002/jcb.22279.
42. Hopson K.P., Truelove J., Chun J., Wang Y., Waeber C. S1P activates store-operated calcium entry via receptor- and non-receptor-mediated pathways in vascular smooth muscle cells. American Journal of Physiology. Cell Physiology 2011, 300(4):C919-C926. 10.1152/ajpcell.00350.2010.
43. Hou X., Pedi L., Diver M.M., Long S.B. Crystal structure of the calcium release-activated calcium channel Orai. Science 2012, 338(6112):1308-1313. 10.1126/science.1228757.
44. House S.J., Potier M., Bisaillon J., Singer H.A., Trebak M. The non-excitable smooth muscle: Calcium signaling and phenotypic switching during vascular disease. Pflügers Archiv 2008, 456(5):769-785. 10.1007/s00424-008-0491-8.
45. Hulot J.S., Fauconnier J., Ramanujam D., Chaanine A., Aubart F., Sassi Y., et al. Critical role for stromal interaction molecule 1 in cardiac hypertrophy. Circulation 2011, 124(7):796-805. 10.1161/CIRCULATIONAHA.111.031229.
46. Hunton D.L., Lucchesi P.A., Pang Y., Cheng X., Dell'Italia L.J., Marchase R.B. Capacitative calcium entry contributes to nuclear factor of activated T-cells nuclear translocation and hypertrophy in cardiomyocytes. The Journal of Biological Chemistry 2002, 277(16):14266-14273. 10.1074/jbc.M107167200.
47. Hunton D.L., Zou L., Pang Y., Marchase R.B. Adult rat cardiomyocytes exhibit capacitative calcium entry. American Journal of Physiology. Heart and Circulatory Physiology 2004, 286(3):H1124-H1132. 10.1152/ajpheart.00162.2003.
48. Jandt E., Mutschke O., Mahboobi S., Uecker A., Platz R., Berndt A., et al. Stent-based release of a selective PDGF-receptor blocker from the bis-indolylmethanon class inhibits restenosis in the rabbit animal model. Vascular Pharmacology 2010, 52(1-2):55-62. 10.1016/j.vph.2009.11.001.
49. Kuang C.Y., Yu Y., Guo R.W., Qian D.H., Wang K., Den M.Y., et al. Silencing stromal interaction molecule 1 by RNA interference inhibits the proliferation and migration of endothelial progenitor cells. Biochemical and Biophysical Research Communications 2010, 398(2):315-320. 10.1016/j.bbrc.2010.06.088.
50. Kuhr F.K., Smith K.A., Song M.Y., Levitan I., Yuan J.X. New mechanisms of pulmonary arterial hypertension: Role of Ca(2)(+) signaling. American Journal of Physiology. Heart and Circulatory Physiology 2012, 302(8):H1546-H1562. 10.1152/ajpheart.00944.2011.
51. 2+ entry into mouse skeletal muscle fibres. The Journal of Physiology 2001, 533(Pt. 1):185-199.
52. Kuwahara K., Wang Y., McAnally J., Richardson J.A., Bassel-Duby R., Hill J.A., et al. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. The Journal of Clinical Investigation 2006, 116(12):3114-3126. 10.1172/JCI27702.
53. 2+ entry in skeletal muscle. Pflügers Archiv 2010, 460(5):813-823. 10.1007/s00424-010-0856-7.
54. 2+-dependent inactivation and gating of the Orai channels. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(34):14687-14692. 10.1073/pnas.0904664106.
55. Levitzki A. PDGF receptor kinase inhibitors for the treatment of restenosis. Cardiovascular Research 2005, 65(3):581-586. 10.1016/j.cardiores.2004.08.008.
56. 2+ entry and endothelial tube formation. Circulation Research 2011, 108(10):1190-1198. 10.1161/CIRCRESAHA.111.243352.
57. 2+ channels with distinct functional properties. Current Biology 2007, 17(9):794-800.
58. 2+ entry is remodelled and controls in vitro angiogenesis in endothelial progenitor cells isolated from tumoral patients. PLoS One 2012, 7(9):e42541. 10.1371/journal.pone.0042541.
59. Lompre A.M., Benard L., Saliba Y., Aubart F., Fauconnier J., Hulot J.S. STIM1 and Orai in cardiac hypertrophy and vascular proliferative diseases. Frontiers in Bioscience (Scholar Edition) 2013, 5:766-773.
60. Madesh M., Hawkins B.J., Milovanova T., Bhanumathy C.D., Joseph S.K., Ramachandrarao S.P., et al. Selective role for superoxide in InsP3 receptor-mediated mitochondrial dysfunction and endothelial apoptosis. The Journal of Cell Biology 2005, 170(7):1079-1090. 10.1083/jcb.200505022.
61. Makiyama Y., Toba K., Kato K., Hirono S., Ozawa T., Saigawa T., et al. Imatinib mesilate inhibits neointimal hyperplasia via growth inhibition of vascular smooth muscle cells in a rat model of balloon injury. The Tohoku Journal of Experimental Medicine 2008, 215(4):299-306.
62. Maranchie J.K., Vasselli J.R., Riss J., Bonifacino J.S., Linehan W.M., Klausner R.D. The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell 2002, 1(3):247-255.
63. 2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. The Journal of Allergy and Clinical Immunology 2009, 124(6). 1311.e7-1318.e7. 10.1016/j.jaci.2009.10.007.
64. McNally B.A., Somasundaram A., Yamashita M., Prakriya M. Gated regulation of CRAC channel ion selectivity by STIM1. Nature 2012, 482(7384):241-245. 10.1038/nature10752.
65. McNally B.A., Yamashita M., Engh A., Prakriya M. Structural determinants of ion permeation in CRAC channels. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(52):22516-22521. 10.1073/pnas.0909574106.
66. Mercer J.C., Dehaven W.I., Smyth J.T., Wedel B., Boyles R.R., Bird G.S., et al. Large store-operated calcium selective currents due to co-expression of Orai1 or Orai2 with the intracellular calcium sensor, Stim1. The Journal of Biological Chemistry 2006, 281(34):24979-24990. 10.1074/jbc.M604589200.
67. Michelakis E.D., Wilkins M.R., Rabinovitch M. Emerging concepts and translational priorities in pulmonary arterial hypertension. Circulation 2008, 118(14):1486-1495. 10.1161/CIRCULATIONAHA.106.673988.
68. Mignen O., Shuttleworth T.J. I(ARC), a novel arachidonate-regulated, noncapacitative Ca(2+) entry channel. The Journal of Biological Chemistry 2000, 275(13):9114-9119.
69. 2+-selective (ARC) channels without store depletion or translocation to the plasma membrane. The Journal of Physiology 2007, 579(Pt. 3):703-715.
70. 2+-selective (ARC) channels. The Journal of Physiology 2008, 586(1):185-195.
71. Mignen O., Thompson J.L., Shuttleworth T.J. Orai1 subunit stoichiometry of the mammalian CRAC channel pore. The Journal of Physiology 2008, 586(2):419-425.
72. 2+-selective ARC channel is a pentameric assembly of Orai1 and Orai3 subunits. The Journal of Physiology 2009, 587(Pt. 17):4181-4197. 10.1113/jphysiol.2009.174193.
73. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93(2):215-228.
74. Motiani R.K., Abdullaev I.F., Trebak M. A novel native store-operated calcium channel encoded by Orai3: Selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells. The Journal of Biological Chemistry 2010, 285(25):19173-19183.
75. 2+-dependent inactivation of CRAC channels. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(36):15495-15500. 10.1073/pnas.0906781106.
76. Myllarniemi M., Calderon L., Lemstrom K., Buchdunger E., Hayry P. Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation. The FASEB Journal 1997, 11(13):1119-1126.
77. Nelken N.A., Soifer S.J., O'Keefe J., Vu T.K., Charo I.F., Coughlin S.R. Thrombin receptor expression in normal and atherosclerotic human arteries. The Journal of Clinical Investigation 1992, 90(4):1614-1621. 10.1172/JCI116031.
78. 2+ entry in mouse pulmonary arterial smooth muscle cells. American Journal of Physiology. Cell Physiology 2010, 299(5):C1079-C1090. 10.1152/ajpcell.00548.2009.
79. 2+ entry by upregulating STIM1/Orai1 via activation of Akt/mTOR in human pulmonary arterial smooth muscle cells. American Journal of Physiology. Cell Physiology 2012, 302(2):C405-C411. 10.1152/ajpcell.00337.2011.
80. Ohba T., Watanabe H., Murakami M., Sato T., Ono K., Ito H. Essential role of STIM1 in the development of cardiomyocyte hypertrophy. Biochemical and Biophysical Research Communications 2009, 389(1):172-176. 10.1016/j.bbrc.2009.08.117.
81. Parekh A.B. Store-operated CRAC channels: Function in health and disease. Nature Reviews. Drug Discovery 2010, 9(5):399-410. 10.1038/nrd3136.
82. Park C.Y., Hoover P.J., Mullins F.M., Bachhawat P., Covington E.D., Raunser S., et al. STIM1 clusters and activates CRAC channels via direct binding of a cytosolic domain to Orai1. Cell 2009, 136(5):876-890. 10.1016/j.cell.2009.02.014.
83. Penna A., Demuro A., Yeromin A.V., Zhang S.L., Safrina O., Parker I., et al. The CRAC channel consists of a tetramer formed by Stim-induced dimerization of Orai dimers. Nature 2008, 456(7218):116-120.
84. Picard C., McCarl C.A., Papolos A., Khalil S., Luthy K., Hivroz C., et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. The New England Journal of Medicine 2009, 360(19):1971-1980. 360/19/1971 [pii]. 10.1056/NEJMoa0900082.
85. Potier M., Gonzalez J.C., Motiani R.K., Abdullaev I.F., Bisaillon J.M., Singer H.A., et al. Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: Role in proliferation and migration. The FASEB Journal 2009, 23(8):2425-2437. 10.1096/fj.09-131128.
86. Prakriya M., Feske S., Gwack Y., Srikanth S., Rao A., Hogan P.G. Orai1 is an essential pore subunit of the CRAC channel. Nature 2006, 443(7108):230-233. 10.1038/nature05122.
87. 2+-inhibited cation (MIC) channels. The Journal of General Physiology 2002, 119(5):487-507.
88. Rafii S., Lyden D., Benezra R., Hattori K., Heissig B. Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy?. Nature Reviews. Cancer 2002, 2(11):826-835. 10.1038/nrc925.
89. Royer L., Rios E. Deconstructing calsequestrin. Complex buffering in the calcium store of skeletal muscle. The Journal of Physiology 2009, 587(Pt. 13):3101-3111. 10.1113/jphysiol.2009.171934.
90. Sanchez-Hernandez Y., Laforenza U., Bonetti E., Fontana J., Dragoni S., Russo M., et al. Store-operated Ca(2+) entry is expressed in human endothelial progenitor cells. Stem Cells and Development 2010, 19(12):1967-1981. 10.1089/scd.2010.0047.
91. Scherberich A., Campos-Toimil M., Ronde P., Takeda K., Beretz A. Migration of human vascular smooth muscle cells involves serum-dependent repeated cytosolic calcium transients. Journal of Cell Science 2000, 113(Pt. 4):653-662.
92. Shaul P.W. Regulation of endothelial nitric oxide synthase: Location, location, location. Annual Review of Physiology 2002, 64:749-774. 10.1146/annurev.physiol.64.081501.155952.
93. Shi Y., Song M., Guo R., Wang H., Gao P., Shi W., et al. Knockdown of stromal interaction molecule 1 attenuates hepatocyte growth factor-induced endothelial progenitor cell proliferation. Experimental Biology and Medicine (Maywood, NJ) 2010, 235(3):317-325. 10.1258/ebm.2009.009237.
94. Shuttleworth T.J. Orai3-The 'exceptional' Orai?. The Journal of Physiology 2012, 590(Pt. 2):241-257. 10.1113/jphysiol.2011.220574.
95. 2+-independent phospholipase A2 and store-operated pathway in urocortin-induced vasodilatation of rat coronary artery. Circulation Research 2007, 101(11):1194-1203. 10.1161/CIRCRESAHA.107.159053.
96. Soboloff J., Rothberg B.S., Madesh M., Gill D.L. STIM proteins: Dynamic calcium signal transducers. Nature Reviews. Molecular Cell Biology 2012, 13(9):549-565. 10.1038/nrm3414.
97. Song M.Y., Makino A., Yuan J.X. STIM2 contributes to enhanced store-operated Ca entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension. Pulmonary Circulation 2011, 1(1):84-94. 10.4103/2045-8932.78106.
98. Spinelli A.M., Gonzalez-Cobos J.C., Zhang X., Motiani R.K., Rowan S., Zhang W., et al. Airway smooth muscle STIM1 and Orai1 are upregulated in asthmatic mice and mediate PDGF-activated SOCE, CRAC currents, proliferation, and migration. Pflügers Archiv 2012, 464(5):481-492. 10.1007/s00424-012-1160-5.
99. Stiber J., Hawkins A., Zhang Z.S., Wang S., Burch J., Graham V., et al. STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle. Nature Cell Biology 2008, 10(6):688-697. 10.1038/ncb1731.
100. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Medicine 1999, 5(4):434-438. 10.1038/7434.
101. 2+ entry and its pharmacological characteristics responsible for endothelium-dependent, NO-mediated relaxation induced by thapsigargin in guinea-pig aorta. The Journal of Pharmacy and Pharmacology 1999, 51(7):831-840.
102. Thyberg J. Differentiated properties and proliferation of arterial smooth muscle cells in culture. International Review of Cytology 1996, 169:183-265.
103. Touchberry C.D., Elmore C.J., Nguyen T.M., Andresen J.J., Zhao X., Orange M., et al. Store-operated calcium entry is present in HL-1 cardiomyocytes and contributes to resting calcium. Biochemical and Biophysical Research Communications 2011, 416(1-2):45-50. 10.1016/j.bbrc.2011.10.133.
104. Trebak M. PLC: Johnny-come-lately to ORAI and the ups and downs of calcium signalling. The Journal of Physiology 2011, 589(Pt. 22):5337-5338. 10.1113/jphysiol.2011.220517.
105. Trebak M. STIM/Orai signalling complexes in vascular smooth muscle. The Journal of Physiology 2012, 590(Pt. 17):4201-4208. 10.1113/jphysiol.2012.233353.
106. Trebak M., Zhang W., Ruhle B., Henkel M.M., Gonzalez-Cobos J.C., Motiani R.K., et al. What role for store-operated Ca(2+) entry in muscle?. Microcirculation 2013, 20(4):330-336. 10.1111/micc.12042.
107. 2+ store depletion in vascular smooth muscle cells. The Journal of Biological Chemistry 2001, 276(11):7782-7790.
108. 2+ entry uncoupled with ryanodine receptor and junctional membrane complex in heart muscle cells. Cell Calcium 2002, 31(2):89-96. 10.1054/ceca.2001.0257.
109. Vig M., DeHaven W.I., Bird G.S., Billingsley J.M., Wang H., Rao P.E., et al. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nature Immunology 2008, 9(1):89-96. 10.1038/ni1550.
110. 2+ entry. Science 2006, 312(5777):1220-1223. 10.1126/science.1127883.
111. Voelkers M., Salz M., Herzog N., Frank D., Dolatabadi N., Frey N., et al. Orai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytes. Journal of Molecular and Cellular Cardiology 2010, 48(6):1329-1334. 10.1016/j.yjmcc.2010.01.020.
112. Volkers M., Dolatabadi N., Gude N., Most P., Sussman M.A., Hassel D. Orai1 deficiency leads to heart failure and skeletal myopathy in zebrafish. Journal of Cell Science 2012, 125(Pt. 2):287-294. 10.1242/jcs.090464.
113. Wang Y., Deng X., Mancarella S., Hendron E., Eguchi S., Soboloff J., et al. The calcium store sensor, STIM1, reciprocally controls Orai and CaV1.2 channels. Science 2010, 330(6000):105-109. 10.1126/science.1191086.
114. 2+/NFAT pathway is involved in the anti-proliferative effect of sildenafil on pulmonary artery smooth muscle cells. Respiratory Research 2009, 10:123. 10.1186/1465-9921-10-123.
115. 2+ signaling in cardiac myocyte excitation-transcription coupling. The Journal of Clinical Investigation 2006, 116(3):675-682. 10.1172/JCI27374.
116. Yamaguchi N., Takahashi N., Xu L., Smithies O., Meissner G. Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel. The Journal of Clinical Investigation 2007, 117(5):1344-1353. 10.1172/JCI29515.
117. Yeromin A.V., Zhang S.L., Jiang W., Yu Y., Safrina O., Cahalan M.D. Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai. Nature 2006, 443(7108):226-229. 10.1038/nature05108.
118. Yuan J.P., Zeng W., Dorwart M.R., Choi Y.J., Worley P.F., Muallem S. SOAR and the polybasic STIM1 domains gate and regulate Orai channels. Nature Cell Biology 2009, 11(3):337-343.
119. Zhang W., Halligan K.E., Zhang X., Bisaillon J.M., Gonzalez-Cobos J.C., Motiani R.K., et al. Orai1-mediated I (CRAC) is essential for neointima formation after vascular injury. Circulation Research 2011, 109(5):534-542. CIRCRESAHA.111.246777 [pii]. 10.1161/CIRCRESAHA.111.246777.
120. Zhang S.L., Yeromin A.V., Zhang X.H., Yu Y., Safrina O., Penna A., et al. Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(24):9357-9362. 10.1073/pnas.0603161103.
121. Zhou Y., Ramachandran S., Oh-Hora M., Rao A., Hogan P.G. Pore architecture of the ORAI1 store-operated calcium channel. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(11):4896-4901. 10.1073/pnas.1001169107.